Vera Therapeutics
VERA
VERA
84 hedge funds and large institutions have $538M invested in Vera Therapeutics in 2023 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 38 increasing their positions, 15 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
84
Holders Change
+8
Holders Change %
+10.53%
% of All Funds
1.34%
Holding in Top 10
5
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-28.57%
% of All Funds
0.08%
New
17
Increased
38
Reduced
15
Closed
8
Calls
$364K
Puts
–
Net Calls
+$364K
Net Calls Change
+$2M
Top Buyers
| 1 |
1
State Street
Boston,
Massachusetts
|
$23.7M |
| 2 |
WP
2
Woodline Partners
San Francisco,
California
|
$35.1M |
| 3 |
3
Axa
Paris,
France
|
$3.72M |
| 4 |
ACM
4
Altium Capital Management
New York
|
$4.57M |
| 5 |
5
BlackRock
New York
|
$32.3M |
Top Sellers
| 1 |
1
Fidelity Investments
Boston,
Massachusetts
|
$74.7M |
| 2 |
CG
2
Carlyle Group
Washington,
District of Columbia
|
$19.7M |
| 3 |
3
Millennium Management
New York
|
$0 |
| 4 |
EP
4
Eversept Partners
New York
|
$20.3M |
| 5 |
O
5
OrbiMed
New York
|
$20.8M |
